Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ligand Pharmaceuticals (LGND) Q2 2023 Earnings
LGND
4
May
Confirmed
Q3 2022
Q4 2022
Q1 2023
Q2 2023
0.44
1.05
1.67
2.28
Details
Expected EPS
0.95
Actual EPS
2.28
Surprise EPS
1.33
Surprise Percent
+140%
Description
Ligand Pharmaceuticals (LGND) has reported earnings of 2.28 per share for Q2 2023.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist